Linda Thai

FDA investigator · also recorded as Of Tes Linda Thai

Appears on 18 documents from 2014 to 2025, mostly at sites in California. Most often cites production record review (21 CFR 211.192).

18
Documents on file
4.4
Observations per 483
2014
First seen
2025
Most recent

What they cite most

From 65 observations

Activity by year

2014: 1, 2015: 1, 2016: 1, 2017: 2, 2018: 2, 2019: 3, 2020: 1, 2021: 3, 2022: 2, 2024: 1, 2025: 1

Where

California 11 · Pennsylvania 2 · Canada 1 · France 1 · Michigan 1 · South Carolina 1

Is Linda Thai coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

18 documents, newest first
FirmOpen
483 Bausch & Lomb IncorporatedFeb 27, 2025 · Greenville, South Carolina
483 Anesta LLCAug 30, 2024 · Salt Lake City, Utah
483 Emergent BioSolutions Canada IncMay 10, 2022 · Winnipeg, Canada
483 BAXALTA US INC.Apr 7, 2022 · THOUSAND OAKS, California
483 Emergent Biodefense Operations Lansing LLCSep 29, 2021 · Lansing, Michigan
483 Novartis Gene Therapies, Inc.Aug 27, 2021 · SAN DIEGO, California
483 Merck Sharp & Dohme LLCJul 27, 2021 · West Point, Pennsylvania

About this profile

What does Linda Thai inspect?

Linda Thai appears on 18 documents on file covering 14 sites, mostly in California.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.42 and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Linda Thai is dated Feb 27, 2025.